This is a developing news story. Please check back soon for updates. Tremfya reduced signs and symptoms of psoriatic ...

Discover the early warning signs of psoriatic arthritis that could prevent permanent joint damage, plus expert advice on treatment options and daily management.

Degenerative disc disease is common among young adults with PsA, with key risk factors including older age, male sex, diabetes, and inflammatory back pain.

Sotyktu significantly outperformed placebo for the treatment of psoriatic arthritis in a phase 3 trial, meeting key endpoints ...

Ultrasound-detected dactylitis lesions may help identify patients with psoriasis who are at risk for psoriatic arthritis and ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

A panelist discusses how real-world evidence from a large cohort study (n = 31521) presented at AAD 2025 reveals notable ...

A new study published in Heliyon has found that people who experienced abuse, neglect, or domestic abuse during childhood ...

A 20-year-old female presented with a history of psoriasis and psoriatic arthritis since childhood. She started treatment with etanercept (Enbrel ®) 1 month previously. One day after a ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

He had not been treated previously. He did not have any other medical problems and did not complain of arthritis. A clinical diagnosis was made of psoriasis and he was prescribed clobetasol ...

It has been tipped as having multibillion-dollar sales potential if it gets approved across several indications, with studies on the go in psoriatic arthritis, lupus, and Sjögren's syndrome.